← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2014Last known activity
Oct 29, 2015
Acquired by PTC Therapeutics on Apr 1, 2017
Timeline
2000s
- Jan 1, 2008
Marathon Pharmaceuticals— Founded
2010s
- Apr 1, 2017
PTC Therapeutics— Acquired By
Drugs by trial phase (4 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT02592941Lead sponsorN/AOct 29, 2015
- NCT02485431Lead sponsorPhase 1Jun 1, 2015
- NCT02246816Lead sponsorPhase 3Feb 1, 2015
- NCT02286622Study directorPhase 1Dec 1, 2014
- NCT02242656Lead sponsorPhase 3Dec 1, 2014
- NCT02251600Lead sponsorPhase 1Dec 1, 2014
- NCT02286609Study directorPhase 1Dec 1, 2014
- NCT02286609Lead sponsorPhase 1Dec 1, 2014
- NCT02295748Lead sponsorPhase 1Dec 1, 2014
- NCT02286622Lead sponsorPhase 1Dec 1, 2014
- NCT02295748Study directorPhase 1Dec 1, 2014
- NCT02286635Study directorPhase 1Nov 1, 2014
- NCT02286635Lead sponsorPhase 1Nov 1, 2014
Details
- Founded
- Northbrook, IL, US Jan 1, 2008
- Last known activity
- Oct 29, 2015
Notes
Acquired by PTC Therapeutics in 2017